'Some Hope Is Better Than Having No Hope'
The Daily

'Some Hope Is Better Than Having No Hope'

Jul 7, 2021
36:59
-(0)

About this episode

When the F.D.A. approved the drug Aduhelm, the first Alzheimer’s treatment to receive the agency’s endorsement in almost two decades, it gave hope to many. But the decision was contentious; some experts say there’s not enough evidence that the treatment can address cognitive symptoms. What is the story behind this new drug? Guest: Pam Belluck, a health and science writer for The New York Times.

Comments

Rate this episode

Episode Details

Author
The New York Times
Show Type
full
Audio Format
audio/mpeg

We use analytics

We use Umami, a privacy-friendly analytics tool, to understand how visitors use this site. No personal data is collected and no data leaves our EU servers. You can accept or decline below. Privacy Policy